Sunil C Kaul

12PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Horticultural crop improvement (incl. selection and breeding)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Selective killing of ALT-cancer cells by Withaferin-A involves destabilization of Rad51 and disruption of DNA repair.

|Jun 28, 2024
Antistress and Antiaging Potentials of Alpha-Lipoic Acid: Insights from Cell Culture-Based Experiments.

Renu Wadhwa, Mangala Hegde, Huayue Zhang

|Apr 16, 2023
Three-Way Cell-Based Screening of Antistress Compounds: Identification, Validation, and Relevance to Old-Age-Related Pathologies.

Huayue Zhang, Jia Wang, Jay Prakash

|Jun 21, 2021
Withanolide Derivative 2,3-Dihydro-3β-methoxy Withaferin-A Modulates the Circadian Clock via Interaction with RAR-Related Orphan Receptor α (RORa).

Tatsunosuke Tomita, Renu Wadhwa, Sunil C Kaul

|Aug 19, 2020
Photothermogenetic inhibition of cancer stemness by near-infrared-light-activatable nanocomplexes.

Yue Yu, Xi Yang, Sheethal Reghu

|Dec 21, 2019
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.

Jayarani F Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal

Pageof 2

Frequent Collaborators

2 joint publications

Yue Yu

1 joint publications

Rajkumar S Kalra

1 joint publications

Nobuhiro Ando

1 joint publications

Sheethal Reghu